Regeneron (REGN)

AI-powered earnings call analysis for Regeneron. Get insights from quarterly earnings reports with our AI-generated podcast. Educational content only - not investment advice.

10 episodes 5 languages

Next Episode

Regeneron earnings call scheduled for Jul 30, 2026 (before market open)

New episode expected Jul 31, 2026

Latest Episode

Q1 2026 Earnings

7:17 • 4/29/2026

Regeneron (REGN) - Q1 2026

0:00

7:17

Speed:

Q1 2026 Earnings

10:16 • 2026/4/29

Regeneron (REGN) - Q1 2026

0:00

10:16

Speed:

Q1 2026 Earnings

11:26 • 29/04/2026

Regeneron (REGN) - Q1 2026

0:00

11:26

Speed:

Q1 2026 Earnings

12:00 • 29/4/2026

Regeneron (REGN) - Q1 2026

0:00

12:00

Speed:

Q1 2026 Earnings

8:50 • 29.4.2026

Regeneron (REGN) - Q1 2026

0:00

8:50

Speed:

All Episodes

EN - English (2) CN - 中文 (2) FR - Français (2) ES - Español (2) DE - Deutsch (2)

Q1 2026 Earnings

7:17

Regeneron delivered 19% revenue growth to $3.6B in Q1 2026 driven by DUPIXENT's 31% expansion and EYLEA HD's 52% surge, while advancing late-stage pipeline programs including cemdisiran for myasthenia gravis with superior efficacy data.